ATE189480T1 - Rekombinantes avipoxvirus - Google Patents

Rekombinantes avipoxvirus

Info

Publication number
ATE189480T1
ATE189480T1 AT92201406T AT92201406T ATE189480T1 AT E189480 T1 ATE189480 T1 AT E189480T1 AT 92201406 T AT92201406 T AT 92201406T AT 92201406 T AT92201406 T AT 92201406T AT E189480 T1 ATE189480 T1 AT E189480T1
Authority
AT
Austria
Prior art keywords
recombinant avipoxvirus
avipoxvirus
recombinant
Prior art date
Application number
AT92201406T
Other languages
English (en)
Inventor
Georges Thiry
Didier Colau
Wannemaeker Catherine De
Daniel Malarme
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Application granted granted Critical
Publication of ATE189480T1 publication Critical patent/ATE189480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT92201406T 1991-05-27 1992-05-19 Rekombinantes avipoxvirus ATE189480T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (1)

Publication Number Publication Date
ATE189480T1 true ATE189480T1 (de) 2000-02-15

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92201406T ATE189480T1 (de) 1991-05-27 1992-05-19 Rekombinantes avipoxvirus

Country Status (23)

Country Link
EP (1) EP0517292B1 (de)
JP (1) JP3411307B2 (de)
KR (1) KR100244601B1 (de)
CN (1) CN1055501C (de)
AR (1) AR248045A1 (de)
AT (1) ATE189480T1 (de)
AU (1) AU656185B2 (de)
BE (1) BE1004877A3 (de)
BR (1) BR9202024A (de)
CA (1) CA2069594A1 (de)
DE (1) DE69230627T2 (de)
DK (1) DK0517292T3 (de)
ES (1) ES2145000T3 (de)
HU (1) HU215531B (de)
IE (1) IE921686A1 (de)
IL (1) IL101780A (de)
MX (1) MX9202512A (de)
NZ (1) NZ242620A (de)
PT (1) PT517292E (de)
RU (1) RU2130971C1 (de)
SG (1) SG49876A1 (de)
TW (1) TW288048B (de)
ZA (1) ZA923321B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0597016A4 (en) * 1991-07-26 1996-04-24 Virogenetics Corp Infectious bursal disease virus recombinant poxvirus vaccine.
PT623172E (pt) * 1992-01-13 2005-02-28 Virogenetics Corp Vacina de virus vaccinia recombinante do virus da doenca de marek
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
WO1994019015A1 (en) * 1993-02-26 1994-09-01 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
US7041439B2 (en) * 2001-04-17 2006-05-09 Embrex, Inc. Methods and apparatus for selectively processing eggs having identified characteristics
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
CA2467486A1 (en) 2001-11-30 2003-06-12 Isis Innovation Limited Vaccine
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
PL218318B1 (pl) * 2002-05-16 2014-11-28 Bavarian Nordic As Rekombinowany wirus krowianki Ankara (MVA), zawierająca go komórka, szczepionka lub kompozycja farmaceutyczna, sposób lub zestaw do jego otrzymywania, sekwencja DNA zawierająca genom tego wirusa oraz sposób wykrywania tego wirusa lub komórek nim zainfekowanych
EP1601333B1 (de) * 2003-02-20 2013-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Neue einführungsstellen in pocken-vektoren
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
SMT201900188T1 (it) 2011-11-30 2019-05-10 Merial Inc Vettori ricombinanti gallid herpesvirus 3 (mdv sierotipo 2) esprimenti antigeni di patogeni aviari e loro utilizzi
EP2845904A1 (de) 2013-09-06 2015-03-11 Ceva Sante Animale Rekombinante Hühner-Herpesviren und deren Verwendungen
EP3050572A1 (de) 2015-01-29 2016-08-03 Ceva Sante Animale Rekombinante MDV1 und Verwendungen davon
EP3263129A1 (de) 2016-06-29 2018-01-03 Ceva Sante Animale Entenenteritisvirus und verwendungen davon
KR102617503B1 (ko) 2016-12-14 2023-12-29 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 조류 병원체의 다중 항원을 발현하는 재조합 hvt 벡터 및 그를 포함하는 백신
EP3902561A1 (de) 2018-12-27 2021-11-03 Ceva Santé Animale Rekombinante viren und verwendungen davon
MA58717A1 (fr) 2020-06-17 2023-06-28 Boehringer Ingelheim Vetmedica Gmbh Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations
TWI812936B (zh) 2021-04-01 2023-08-21 智勝科技股份有限公司 研磨墊及研磨方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
WO1989012684A1 (en) * 1988-06-24 1989-12-28 National Research Development Corporation Fowlpox virus non-essential regions
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
KR940001265B1 (ko) * 1988-12-29 1994-02-18 닛뽕 제온 가부시끼가이샤 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스
EP0474676A4 (en) * 1989-05-30 1993-02-24 The Commonwealth Scientific And Industrial Research Organization Production of ibdv vp2 in highly immunogenic form

Also Published As

Publication number Publication date
IL101780A (en) 2000-12-06
HU9201746D0 (en) 1992-08-28
AU1632392A (en) 1992-12-03
HUT62331A (en) 1993-04-28
RU2130971C1 (ru) 1999-05-27
JPH05244939A (ja) 1993-09-24
HU215531B (hu) 2000-05-28
BR9202024A (pt) 1993-01-19
IL101780A0 (en) 1992-12-30
TW288048B (de) 1996-10-11
DE69230627T2 (de) 2000-09-28
DE69230627D1 (de) 2000-03-09
AR248045A1 (es) 1995-05-31
MX9202512A (es) 1995-01-31
CN1055501C (zh) 2000-08-16
PT517292E (pt) 2000-06-30
KR920021706A (ko) 1992-12-18
CA2069594A1 (fr) 1992-11-28
IE921686A1 (en) 1992-12-02
AU656185B2 (en) 1995-01-27
BE1004877A3 (fr) 1993-02-16
ES2145000T3 (es) 2000-07-01
EP0517292B1 (de) 2000-02-02
DK0517292T3 (da) 2000-05-08
KR100244601B1 (ko) 2000-03-02
ZA923321B (en) 1993-01-27
EP0517292A1 (de) 1992-12-09
NZ242620A (en) 1993-09-27
SG49876A1 (en) 2002-04-16
JP3411307B2 (ja) 2003-05-26
CN1069068A (zh) 1993-02-17

Similar Documents

Publication Publication Date Title
FI923737L (fi) Rekombinantantikroppar specifika foer tnfa
FI933757L (fi) Expression av rekombinantproteiner i attenuerade bakterier
NO942066L (no) Peptidderivater
DE59209205D1 (de) Schnittstelle
FI892714A0 (fi) Rekombinant-coccidiosisvaccin.
FI934541A0 (fi) Antibakteriellt milt flytande hudrengoeringsmedel
FI933655L (fi) Reducerad polydextros
FI933674A0 (fi) Foerstaerkningsregleringssystem foer radiosaendare
FI921782A7 (fi) Torrmalapparat
DE69230432D1 (de) Photoelektischer schalter
DE69230961D1 (de) DMA-Steuerung
DE69230627D1 (de) Rekombinantes Avipoxvirus
FI925787L (fi) Proteolytiska enzymers sackarinderivatinhibitorer
FI945928L (fi) Rekombinanttiksylanaasit
FI935315A0 (fi) En flat packningscontainer
FI941758L (fi) Rekombitooppipeptidejä
FI930118L (fi) Kylande anordning
FI910398L (fi) Rekombinant coccidiosisvaccin -5-7-eimeria-ytantigen.
FI933495L (fi) Rekombinantadenovirusvacciner
FI943626L (fi) Rekombinanttiadenovirusrokotteita
FI925166A0 (fi) Proteolytiska enzymer inhibiterande sackarinderivat
FI934588A0 (fi) Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
FI88467B (fi) Anordning foer skaerbraenning under vattnet
FI923311L (fi) Proteiner
DK56591D0 (da) Toerringsfremgangsmaade

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee